Investigational Brensocatib Reduces Exacerbations Across Most Bronchiectasis Subgroups
New sub-analyses show that brensocatib reduced pulmonary exacerbations and slowed lung function decline for most subgroups of patients with non-cystic fibrosis bronchiectasis.